3Young NS. Hematopoietic cell destruction by immune mechanismsn acquired aplastic anemia [J]. Semin Hematol,2000,37(1):3-14.
4Nakao S, Taka matsu H, Takami A, et al. Immunosuppressive treatm- ent of aplastic anemia with antithymocyte globulin and eyclosporine [J] .B 10od, 1997,89 ( 10 ):3691-3699.
5Teramura M, Kobayashi S, Iwabe K, et al. Cyclophosphamide and other new agent for the treatment of severe aplastic anemia [J]. Haematol,1997,96(23 ) : 80-84.
6Tom V, Anna M, Inderjeet D, et al. Association between aplastic anemia and mutations in telomerase [J]. RNA. Lancet,2002,359(13): 21-68.
7Araga S, Kishimoto M, Adachi A, et al. The CD5+ B cells and asthenia gravis[J]. Autoimmunity, 1995,20 (2): 129-134.
8Corrales JJ, Orfao A, Lopez A, et al. CD5+ B cells in Graves disease correlation with disease activity [J]. Horm Metab Res,1996,28 (6): 280-285.
9Stein SH, Hart TE, HoffmanWH, et al. Interleukin210 promotes anticollagen antibody production in type I diabetic peripheral B lymphocytes[J]. Periodontal Res, 1997,32(12): 189-195.
10Stein SH, Hart TE, Hoffrnan WH, et al. Interleukin-10 promotes anticollagen antibody production in type I diabetic peripheral B lymphocytes[J]. Periodontal Res, 1997,32:189-195.
